Core Viewpoint - Coty Inc. is under investigation for potential violations of federal securities laws, following disappointing financial results and claims of overstated demand for its Prestige fragrances [1][2][3]. Group 1: Company Overview - Coty Inc. is one of the largest beauty companies globally, with a diverse portfolio that includes fragrance, color cosmetics, and skin and body care products [2]. - Prestige fragrances represent 60% of Coty's revenues, indicating a significant reliance on this segment [2]. Group 2: Financial Performance - On August 20, 2025, Coty reported disappointing financial results for Q4 and FY 2025, citing issues such as weaknesses in U.S. execution and retailer inventory buildup [3]. - The company's stock price fell by $1.05, a decline of over 21%, from $4.86 to $3.81 per share following the announcement of these results [3]. Group 3: Market Dynamics - Coty indicated that the slowdown in cosmetics sales was influenced by value-seeking consumer behavior, fatigue with innovation, and specific U.S. factors such as in-store security measures and immigration policy changes [3].

贝伦贝格将科蒂集团的目标价从6.5美元下调至5.05美元，评级从"买入"降至"持有"。(格隆汇) ...

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Coty Inc. (“Coty” or the “Company”) (NYSE: COTY).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Coty and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On August 20, 2025, Coty issu ...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.Canaccord Genuity analyst Austin Moeller downgraded Bioceres Crop Solutions Corp. BIOX from Buy to Hold and lowered the price target from $6.5 to $2.5. Bioceres Crop Solutions shares closed at $2.24 on Tuesday. See how other analysts view this stock.Compass Point analyst Floris Van Dijkum downgraded BXP, Inc. ...

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Coty Inc. (NYSE: COTY) for potential violations of the federal securities laws. If you invested in Coty, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/coty-inc-class-action. Why Is Coty being Investigated?Coty is one of the world’s largest beauty companies with a portfolio of brands across fragrance, color cosmetics, and skin and ...

NEW YORK, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Coty Inc. (NYSE: COTY) for potential violations of the federal securities laws. If you invested in Coty, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases/coty-inc-class-action. Why Is Coty being Investigated?Coty is one of the world’s largest beauty companies with a portfolio of brands across fragrance, color cosmetics, and skin and ...

营收净利双降，香水巨头科蒂（COTY）交出的2025财年成绩单并不尽如人意。9月3日，新京报贝壳财经记者获 悉，科蒂集团发布截至6月30日的2025财年业绩数据，报告期内，该公司实现净营收58.93亿美元，同比下滑 3.68%；净利润-3.81亿美元，同比由盈转亏，上年同期为7620万美元。 在科蒂集团首席执行官Sue Nabi看来，2025财年公司业绩"跳水"受到多重因素影响，包括美国市场疲软、零售商 去库存、香水业务自2024财年录得强劲表现后增势放缓、大众彩妆承压等，但其仍对接下来的发展持有信心，"我 们迅速采取一系列行动，使科蒂重回持续盈利增长轨道。" 大众美妆业务净营收连续四个季度下滑 成立于1904年的科蒂集团在美妆市场一直享有举足轻重的地位，旗下拥有一系列标志性品牌，涵盖香水、彩妆、 护肤和身体护理等品类，在全球超120多个国家和地区销售。 此前，Sue Nabi称2025财年是科蒂的"过渡之年"——在高端美妆业务方面，正面临香水市场增长放缓、去年新品 上市带来的高基数、零售商消化过剩库存的三重挑战；在大众美妆业务方面，公司已重新调整业务，以应对彩妆 与香水市场日趋分化的发展趋势。 从业绩表现来 ...

Core Viewpoint - The Schall Law Firm is investigating Coty Inc. for potential violations of securities laws following disappointing financial results for Q4 and FY 2025, which led to a significant drop in share price [1][2]. Financial Performance - Coty reported Q4 and FY 2025 financial results on August 20, 2025, which disappointed the market [2]. - The company attributed its poor performance to delays in identifying weaknesses in U.S. execution, retailer inventory buildup, and challenges from previous fiscal year innovations [2]. - A decline in the cosmetics sector was noted, driven by value-seeking behavior, fatigue with innovation, and U.S.-specific factors such as in-store and anti-theft measures and immigration policy changes [2]. - Following the announcement, Coty's shares fell by more than 21% the next day [2].

I give a hold rating for Coty Inc. (NYSE: COTY ) as I believe its issues in the US, weakening Consumer Beauty portfolio, and destocking cycle will continue to weigh on performance. Combined with a poorI’m a fundamental, valuation-driven investor with a strong focus on identifying businesses that have the potential to scale over time and unlock massive terminal value. My investment approach centers around understanding the core economics of a business—its competitive moat, unit economics, reinvestment runway ...

SAN FRANCISCO, Sept. 02, 2025 (GLOBE NEWSWIRE) -- On August 21, 2025, investors in Coty Inc. (NYSE: COTY) saw the price of their shares fall $1.05 (-21%) after the company reported its FY 2025 and Q4 financial results and revealed ongoing inventory destocking issues. The company’s earnings disclosures have prompted national shareholders rights firm Hagens Berman to open an investigation into whether Coty may have misled investors about its growth prospects. The firm urges investors in Coty who suffered sign ...